e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative metabolomic study of lung cancer based on serum, urine and bronchoalveolar lavage fluid.
B. Urizar Catalan (Huelva, Spain)
Source:
International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Session:
Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Session type:
Oral Presentation
Number:
4866
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Urizar Catalan (Huelva, Spain). Comparative metabolomic study of lung cancer based on serum, urine and bronchoalveolar lavage fluid.. 4866
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung cancer metabolomics in plasma, urine and broncheoalveolar lavage. A pilot study
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
Source: ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020
Year: 2021
Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Comparative proteomics of human bronchoalveolar lavage fluid from COPD and non-COPD subjects
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Biochemical markers in bronchoalveolar lavage (BAL)
Source: Eur Respir J 2001; 18: Suppl. 33, 385s
Year: 2001
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Physiological correlations between urea and total protein in breath condensate, bronchoalveolar lavage fluid and serum (animal model)
Source: Eur Respir J 2001; 18: Suppl. 33, 366s
Year: 2001
Altered expression of bronchoalveolar lavage fluid proteins in sarcoidosis: A proteomics approach
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
Liquid biopsy in patients with adenocarcinoma -comparison between bronchoalveolar lavage (BAL) and blood samples
Source: Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons
Year: 2020
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
Cytokine profile in lung cancer microenvironment- analysis of bronchoalveolar lavage fluid by Luminex assay
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Comparative study between different methods of aliquots suction during bronchoalveolar lavage
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept